Derek Jellinek

Prior to joining Morgans in 2015, Derek was with CIMB and RBS for five years as a healthcare analyst, bringing many years of experience and in-depth knowledge of both domestic and international equity markets. Derek has also worked in a similar capacity for several US-based investment banks and has more than three years of experience in biopharmaceutical commercial development.